Philippe Genne is the founder of Oncodesign. Oncodesign has raised $46M in total funding. Latest round: Growth. Based in Dijon, France.
Philippe Genne is the President of Oncodesign Precision Medicine (OPM), a biotechnology company founded in September 2022. OPM emerged from the split of Oncodesign SA and focuses on discovering effective treatments for resistant and metastatic cancers. The company was listed on Euronext Growth in Paris in December 2022 and has developed a precision medicine platform with proprietary technologies such as Nanocyclix, Oncosniper, and Promethe.
Full founder directory · Investor directory · Company funding database · Fundraising library